chartexchange

Travere Crashed Into Its 200-Day Line And Then Reversed Higher; Here's Why

Investor's Business Daily | Nov 3, 2026 9:23 AM EST

Shares of Travere Therapeutics took a hit Tuesday, but closed in the green, after fewer than expected patients started taking its drug.
The post Travere Crashed Into Its 200-Day Line And Then Reversed Higher; Here's Why appeared first on Investor's Business Daily .

Read original article